When sample, clinical, and biomarker data live in different systems, signal detection slows—and confidence in decisions erodes.
See how top pharmas are using QuartzBio’s solutions to unify their data ecosystem:
Translational research teams report spending more than 90% of their time wrangling data instead of analyzing it.
What if you didn’t have to work this way? QuartzBio’s Biomarker Intelligence (BI) solution automatically ingests and harmonizes sample, clinical, and biomarker data across the entire portfolio, so translational teams can surface efficacy and safety signals in seconds, not weeks.
With Biomarker Intelligence, translational teams can:
If you’re tired of chasing your data around a disconnected ecosystem, see how our Biomarker Intelligence (BI) Solution can help by enabling portfolio-wide insights across sample, clinical, and biomarker data.
Translational teams at an oncology biotech used our Biomarker Intelligence solution to solve the problems of patient qualification and stratification by integrating data across clinical programs.
See how a team like yours:
Discover where your team could gain novel insights across clinical programs with a 15-minute workflow review!
QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.
QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio, in the United States and/or other jurisdictions. All rights reserved.
© 2026. All rights reserved.
QuartzBio, Inc.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.